These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35575008)

  • 21. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
    Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate diethyl ester-loaded lipid-core nanocapsules in aqueous solution increased antineoplastic effects in resistant breast cancer cell line.
    Yurgel VC; Oliveira CP; Begnini KR; Schultze E; Thurow HS; Leon PM; Dellagostin OA; Campos VF; Beck RC; Guterres SS; Collares T; Pohlmann AR; Seixas FK
    Int J Nanomedicine; 2014; 9():1583-91. PubMed ID: 24741306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer.
    Nur SG; Buket O; Sezgi K; Cagdas A; Cansu A; Guliz A; Habibe Y; Cigir BA; Yavuz D; Senay HS
    Anticancer Agents Med Chem; 2016; 16(8):1038-1042. PubMed ID: 26721835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells.
    Park JS; Lee D; Yang S; Jeong HY; Na HS; Cho KH; Choi J; Koo H; Cho ML; Park SH
    J Transl Med; 2022 Feb; 20(1):85. PubMed ID: 35148758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
    Katiyar SS; Kushwah V; Dora CP; Jain S
    Int J Pharm; 2019 Feb; 557():86-96. PubMed ID: 30584909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics.
    Garg NK; Singh B; Kushwah V; Tyagi RK; Sharma R; Jain S; Katare OP
    Nanomedicine; 2016 Oct; 12(7):2043-2060. PubMed ID: 27234306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
    Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
    Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifunctional nanomedicine platform for co-delivery of methotrexate and mild hyperthermia towards breast cancer therapy.
    Ong YS; Bañobre-López M; Costa Lima SA; Reis S
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111255. PubMed ID: 32806240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photolytic Controlled Release Formulation of Methotrexate Loaded in Chitosan/TiO
    Al-Nemrawi N; Hameedat F; Al-Husein B; Nimrawi S
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
    Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
    J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Chemo-Photothermal Therapy in Breast Cancer Using Methotrexate-Loaded Folic Acid Conjugated Au@SiO
    Agabeigi R; Rasta SH; Rahmati-Yamchi M; Salehi R; Alizadeh E
    Nanoscale Res Lett; 2020 Mar; 15(1):62. PubMed ID: 32189075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.
    Wu P; He X; Wang K; Tan W; He C; Zheng M
    J Biomed Nanotechnol; 2009 Oct; 5(5):557-64. PubMed ID: 20201432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.
    Ait Bachir Z; Huang Y; He M; Huang L; Hou X; Chen R; Gao F
    Int J Nanomedicine; 2018; 13():5657-5671. PubMed ID: 30288039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
    Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
    Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication of methotrexate-loaded gold nanoconjugates and its enhanced anticancer activity in breast cancer.
    Chaudhari R; Patel P; Meghani N; Nasra S; Kumar A
    3 Biotech; 2021 Apr; 11(4):175. PubMed ID: 33927966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects.
    Fan Z; Wang Y; Xiang S; Zuo W; Huang D; Jiang B; Sun H; Yin W; Xie L; Hou Z
    J Mater Chem B; 2020 Mar; 8(9):1922-1934. PubMed ID: 32052817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
    Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
    Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
    Hashad RA; Ishak RA; Geneidi AS; Mansour S
    Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.